RENO, Nev., March 4, 2005 (PRIMEZONE) -- Martin Nutraceutical Inc. (Pink Sheets:MTNU) today commented on a recent report from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, which reported that one in seven Americans suffer from some sort of Arthritic pain. It is estimated that over 40% of North Americans suffer from severe disabling of the joints or muscle pain that severely affects their quality of life.
Currently in North America, over $3.9 billion is spent on over the counter and prescription medication for arthritis, joint and muscle related pain. Many of these products come with serious and even deadly side effects, most recently cited: VIOXX and other Non-Steroidal Anti-Inflammatory drugs.
Last Year, North Americans spent approximately $400 million on Glucosamine supplements that have proven to reduce pain, but only in large joints such as the knee and the hip. Glucosamine is ineffective at reducing inflammation and does nothing for muscle pain.
Perhaps one of the biggest disadvantages surrounding the use of Glucosamine and Chondroitin Sulfate is the lengthy reaction time that is required before any effect has taken place, if any has at all. Glucosamine and Chondroitin Sulfate have been well documented to show that less than 50% of those taking these supplements notice any difference in their joint pain and for others expecting relief can surpass 18 months in waiting time.
For several years, Dr. AW Martin, DC, PhD, RNCP, DNM, a Canadian researcher, has studied the effects of enzyme therapy on pain and inflammation. Dr. Martin has developed a unique blend of proprietary and patented "systemic oral enzymes" designed to provide superior anti-inflammatory benefits. Studies have shown that Dr. Martin's Joint Therapy's, proprietary enzyme formula reduces pain and inflammation in 80% of patients who are diagnosed with Osteoarthritis of the knees in less than 6 weeks. Within this test group, 20% described their relief as dramatic with almost complete relief of all pain and swelling.
In another study conducted for patients suffering with Fibromyalgia -- a severe muscle pain syndrome that effects more than 20 million North Americans -- 90% of patients reported relief from swelling and pain within four weeks of using Dr. Martin's Joint Therapy formula.
Martin Nutraceuticals' Joint Therapy is an all-natural unique blend of system enzymes designed to provide superior anti-inflammatory benefits by breaking down harmful protein and facilitating its removal from the body. Martin Nutraceuticals Joint Therapy has also shown to have an affect on improving blood flow and regulating the immune system, resulting in a faster healing process.
Martin Nutraceuticals is just concluding launch plans for the Joint Therapy product into the United States and Canada for the second quarter of 2005.
Forward Looking Statements
The management of the company, who take full responsibility for its content, prepared this press release. Statements in this news release concerning the company's business outlook or future economic performance, anticipated profitability, revenues, expenses, or other financial items; and statements concerning assumptions made or expectations as to any future events, conditions, performance or other matters, are "forward-looking statements" as that term is defined under the Federal Securities Laws. Forward-looking statements are subject to risks, uncertainties and other factors which could cause actual results to differ materially from those contained in such statements. Such risks, uncertainties and factors include, but are not limited to, future capital needs, changes and delays in product development plans and schedules, customer acceptance of new products, changes in pricing or other actions by competitors, and general economic conditions.
For more information please visit www.martinnutra.com or contact (780) 707-0587